Lataa...
Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases
Bone metastases (BM) often induce skeletal-related events (SREs) and contribute to poor prognoses in patients with cancer. Osteoclast inhibitors (OIs), such as bisphosphonates (BPs) and denosumab, reportedly prevent SREs and improve quality of life in patients with non-small cell lung cancer and BM,...
Tallennettuna:
| Julkaisussa: | Mol Clin Oncol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174393/ https://ncbi.nlm.nih.gov/pubmed/30345052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1710 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|